SSX6P

Across TCGA pan-cancer cohorts, SSX6P RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated SSX6P data layer compared with 6 for mutation status.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher SSX6P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated SSX6P expression acts as an unfavorable survival marker, although some lineages such as UCS and BLCA show a favorable association.

LIHC, UCS, and DLBC are the cancer types where SSX6P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Tertile	III,IV	0.303	0.606	<.001	87	view →
UCS	OS	Tertile	II,III,IV	0.717	0.249	.005	60	view →
DLBC	OS	Tertile	All	0.432	0.855	<.001	48	view →
BLCA	DFS	Tertile	III,IV	0.650	0.520	.016	42	view →
KIRC	DFS	Quartile	All	0.715	0.838	.001	42	view →
LUSC	OS	Tertile	IV	0.001	0.673	.014	36	view →
ACC	DFS	Median	All	0.772	0.431	.014	31	view →
KIRP	OS	Tertile	All	0.754	0.918	.001	30	view →
CHOL	OS	Tertile	II,III,IV	0.024	0.601	.025	18	view →
KICH	OS	Tertile	III,IV	0.178	0.847	<.001	18	view →
THYM	DFS	Tertile	II,III,IV	0.254	0.791	.010	12	view →
TGCT	DFS	Quartile	III,IV	0.340	1.000	.016	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

SSX6P–LIHC (OS)

Open the LIHC breakdown →